Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Inhibitors of Na+/H+ exchange remain a focus of research at Aventis

June 5, 2000

Vivus seeks E.U. marketing approval for Alibra

June 1, 2000

Australian researchers discover novel conotoxin peptides that inhibit neuronal amine transporters

May 31, 2000

CVT-124 assessed in cirrhotic patients with ascites

May 29, 2000

Senetek acquires rights to novel compounds for topical treatment of sexual dysfunction

May 26, 2000

VPA-985 useful in hyponatremia

May 25, 2000

Therapeutic and marketing potential expand for Cystistat

May 25, 2000

Two new series of PDE5 inhibitors claimed by Pfizer

May 19, 2000

New class of peptides useful as selective alpha1-adrenoceptor antagonists

May 18, 2000

FDA requests additional animal data for Vasomax

May 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...